Ensign Peak Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
Ensign Peak Advisors's MEDP Position: Q3 2026 in Review
Ensign Peak Advisors reduced its Medpace (MEDP) stake by 27% in Q3 2026, selling an estimated $2.64M and leaving 12,122 shares worth $7.57M. The position accounts for 0.01% of the portfolio, ranked #494.
Ensign Peak Advisors first reported a position in MEDP in Q4 2019 and has held it in 28 quarters since. The position peaked at $17.1M in Q4 2025. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.
- Ensign Peak Advisors held 12,122 shares of Medpace worth $7.57M as of Q3 2026.
- Ensign Peak Advisors sold 4,503 Medpace shares in Q3 2026, an estimated $2.64M.
- Medpace made up 0.01% of Ensign Peak Advisors's portfolio in Q3 2026, its #494 holding.
- Ensign Peak Advisors first reported a position in Medpace in Q4 2019 and has held it in 28 quarters since.
- Ensign Peak Advisors's Medpace position peaked at $17.1M in Q4 2025.
- 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.
Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.